Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/HCT Testing), By End-use (Central Laboratories, Primary Clinics), By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global clinical laboratory tests market size was exhibited at USD 104.19 billion in 2022 and is projected to hit around USD 258.21 billion by 2032, growing at a CAGR of 9.5% during the forecast period 2023 to 2032.

Key Pointers:

• The HbA1c tests segment held the largest share of market in 2022.
• The HGB/HCT tests segment is expected to show the fastest growth rate over the forecast period.
• The primary clinics segment held the largest share of the clinical laboratory tests market in 2022. 
• The central laboratories segment is expected to show the fastest growth over the forecast period.
• North America held the largest share of the market in 2022 
• Asia Pacific is estimated to show the fastest growth in the clinical laboratory tests market over the forecast period.

Clinical Laboratory Tests Market Report Scope

The clinical laboratory tests market is witnessing growth due to factors such as the rising geriatric population, the growing prevalence of target diseases, and the introduction of innovative solutions to meet the growing demand of the market for clinical tests. The healthcare and diagnostics industry has been largely impacted by the spread of COVID-19. The clinical laboratory tests market has witnessed adverse effects of the pandemic. For instance, LabCorp experienced a decline in overall sales of 8.9% in 2020. This can also be attributed to the overall decline in the number of routine health checkups during the pandemic, leading to a decrease in the number of clinical chemistry tests conducted. However, the number of tests conducted has rebounded to normal, which implies that COVID-19 pandemic has had no long-term adverse impact on the market.

According to the WHO, life expectancy is now exceeding 80 years in most developed economies. Aging is influenced by the interaction of several environmental and genetic factors that affect immunity and metabolism, affecting the function of organs, and is characterized as a substantial risk factor for infectious disease development. Thus, screening and diagnostics can play an important role in the management of overall health. Thus, with an increase in the geriatric population, the need for acute and long-term healthcare is also rising, thereby driving the growth of the global market.

Moreover, the introduction of innovative solutions for maximizing efficiency and minimizing errors is expected to serve this market as a high-impact rendering driver. Integrated workflow management systems, database management tools, and patient test records are gaining importance in the healthcare industry, with companies processing as many as 100 to 150 billion samples per year. Implementation and development of data management and informatics solutions for facilitating smooth operations are expected to drive the growth of this market.

However, the market growth is restrained by the ambiguous regulatory framework associated with clinical laboratory tests. The healthcare industry is largely dependent on regulatory frameworks established by organizations such as the U.S. FDA and EMA. There are no clear regulatory guidelines for the diagnostic sector in developing countries such as China and India. The FDA has the authority to regulate laboratory-developed tests that refer to delivering efficient and rapid results and in-house clinical laboratories developing tests. Risks associated with LDTs may have a negative effect on profit margins and may lead to delays in commercialization of newly developed tests.

Some of the prominent players in the Clinical Laboratory Tests Market include:

• Quest Diagnostics Incorporated.
• Abbott
• Cinven
• Laboratory Corporation of America Holdings
• ARUP Laboratories
• OPKO Health, Inc.
• UNILABS
• Clinical Reference Laboratory, Inc.
• Synnovis Group LLP
• Sonic Healthcare Limited.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Clinical Laboratory Tests market.

By  Type 

• Complete Blood Count
• HGB/ HCT testing
• Basic Metabolic Panel Testing
• BUN Creatinine Testing
• Electrolytes Testing
• HbA1c Testing
• Comprehensive Metabolic Panel Testing
• Liver Panel Testing
  • Hepatitis
  • Bile Duct Obstruction
  • Liver Cirrhosis
  • Liver Cancer
  • Bone Disease
  • Autoimmune Disorders
  • Others
• Renal Panel Testing
• Lipid Panel Testing
• Cardiovascular Panel Tests

By  End-use 

• Central Laboratories
  • Complete Blood Count
  • HGB/ HCT testing
  • Basic Metabolic Panel Testing
  • BUN Creatinine Testing
  • Electrolytes Testing
  • HbA1c Testing
  • Comprehensive Metabolic Panel Testing
  • Liver Panel Testing
  • Renal Panel Testing
  • Lipid Panel Testing
  • Cardiovascular Panel Tests
• Primary Clinics
  • Complete Blood Count
  • HGB/ HCT testing
  • Basic Metabolic Panel Testing
  • BUN Creatinine Testing
  • Electrolytes Testing
  • HbA1c Testing
  • Comprehensive Metabolic Panel Testing
  • Liver Panel Testing
  • Renal Panel Testing
  • Lipid Panel Testing
  • Cardiovascular Panel Tests

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)